Development of Ligand Incorporated Chitosan Nanoparticles for the Selective Delivery of 5-Fluorouracil to Colon

被引:0
作者
Li, Puwang [1 ,2 ,3 ]
Peng, Zheng [3 ]
She, F. H. [1 ]
Kong, L. X. [1 ]
机构
[1] Deakin Univ, Ctr Mat & Fiber Innovat, Inst Technol Res Innovat, Geelong, Vic 3217, Australia
[2] Chinese Acad Trop Agr Sci, Res Inst Trop Agr Machinery, Zhanjiang 524091, Peoples R China
[3] Chinese Acad Trop Agr Sci, Inst Agr Prod Proc Res, Zhanjiang, Peoples R China
来源
NEW AND ADVANCED MATERIALS, PTS 1 AND 2 | 2011年 / 197-198卷
关键词
Chitosan; Folate; Drug Delivery Systems; Nanoparticles; DRUG-DELIVERY; IN-VITRO; CANCER;
D O I
10.4028/www.scientific.net/AMR.197-198.238
中图分类号
TH [机械、仪表工业];
学科分类号
0802 ;
摘要
Drug delivery systems with active targeting ligand provide improved therapeutic efficiency due to the selectivity towards tumor cells. In this paper we prepared drug loaded nanoparticles (NPs) using folate (FA) incorporated chitosan (FA-CS) based on ionic gelation technology. FA-CS NPs were spherical in shape with an average particle size of 100 nm, while 5-fluorouracil (5-FU) loaded NPs became less circular with average particle size of 100-500 nm. NPs made from FA-CS conjugates exhibited improved capability to encapsulate hydrophilic 5-FU. It was found 5-FU distributed in FA-CS NPs in solid solution state. In vitro release results demonstrated the release of 5-FU from FA-CS NPs was more controllable as compared to that of CS NPs.
引用
收藏
页码:238 / +
页数:2
相关论文
共 10 条
[1]   Active targeting schemes for nanoparticle systems in cancer therapeutics [J].
Byrne, James D. ;
Betancourt, Tania ;
Brannon-Peppas, Lisa .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (15) :1615-1626
[2]   A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development [J].
Gupta, VK ;
Beckert, TE ;
Price, JC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 213 (1-2) :83-91
[3]   In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors [J].
Jain, Anekant ;
Jain, Sanjay K. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 35 (05) :404-416
[4]   In vitro study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery [J].
Leopold, CS ;
Friend, DR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 126 (1-2) :139-145
[5]   Folate receptor-targeted drugs for cancer and inflammatory diseases - Preface [J].
Low, PS ;
Antony, AC .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (08) :1055-1058
[6]   Characterization of folate-chitosan-DNA nanoparticles for gene therapy [J].
Mansouri, S ;
Cuie, Y ;
Winnik, F ;
Shi, Q ;
Lavigne, P ;
Benderdour, M ;
Beaumont, E ;
Fernandes, JC .
BIOMATERIALS, 2006, 27 (09) :2060-2065
[7]   Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid [J].
Wiwattanapatapee, R ;
Lomlim, L ;
Saramunee, K .
JOURNAL OF CONTROLLED RELEASE, 2003, 88 (01) :1-9
[8]   A folate receptor-targeted liposomal formulation for paclitaxel [J].
Wu, Jun ;
Liu, Qing ;
Lee, Robert J. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 316 (1-2) :148-153
[9]   Pteroyl-γ-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes [J].
Zhang, YH ;
Guo, LL ;
Roeske, RW ;
Antony, AC ;
Jayaram, HN .
ANALYTICAL BIOCHEMISTRY, 2004, 332 (01) :168-177
[10]   Study on colon-specific 5-Fu pH-enzyme Di-dependent chitosan microspheres [J].
Zhao, Xiu-Li ;
Li, Ke-Xin ;
Zhao, Xu-Feng ;
Pang, Da-Hai ;
Chen, Da-Wei .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, 56 (07) :963-968